Schrodinger
IPOSchrödinger - Physics-based Software Platform for Molecular Discovery & Design
Public · New York, United States · Founded 1990 · $195.0M raised
- Headquarters
- New York, New York
- Employees
- 1001–5000
- Founded
- 1990
- Business Model
- B2B
- Total Funding
- $195.0M
- Last Round
- $110.0M Series EMay 2019
- Rounds
- 2
- Type
- Public
About
Schrödinger develops physics-based computational platforms for drug discovery and materials science. Its software suite—including Maestro, FEP+, and LiveDesign—enables pharmaceutical, biotech, and materials companies to accelerate molecular design. The company also advances its own clinical-stage pipeline with programs in oncology and rare diseases.
Summary
Schrodinger is an Artificial Intelligence company based in New York, United States, founded in 1990. It has raised $195.0M in total across 2 rounds, most recently a $110.0M Series E round in May 2019. Investors include Invus, Pavilion Capital and Laurion Capital Management.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2020
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company
Biopharmaceutical services company
